Shaping the Future of Pharmaceutical Innovation

At DAISA Biopharma, we combine scientific expertise with advanced research capabilities to support global drug discovery and development.

About DAISA Biopharma

We are a multidisciplinary research organization specializing in Medicinal Chemistry, Process Chemistry, and Biocatalysis—delivering scalable, efficient, and sustainable solutions for complex scientific challenges.

OUR TEAM

dr-samad-hossain-daisa

Dr. Samad Hossain

Managing Partner and Founder

 Dr. Samad Hossain earned his Ph.D. in 2012 from the Indian Institute of Chemical Technology (IICT), Hyderabad, India, where he conducted research on natural product total synthesis under the supervision of J. S. Yadav. Following his doctoral studies, he joined Invictus Oncology as a Research Scientist, where he worked on lipid nanoparticle- and human serum albumin-based drug delivery systems for anticancer therapeutics.

In 2019, Dr. Hossain joined AAP Pharma, Hyderabad, where he was responsible for process research and development, kilogram-scale  API synthesis. In 2025, he moved on from AAP Pharma to establish Daisa Biopharma. Dr. Hossain has published six research articles  and holds five patents. Dr Hossain has 14+ years R&D experience in the pharmaceutical industry and have in-depth knowledge in process optimization and manufacturing of API and specialty chemicals

dr-bali-reddy-daisa-biopharma

Dr. Bali Reddy

Principal Scientist - 1

Dr. Perla Venkata Bali Reddy, a graduate of Sri Krishnadevaraya University, earned his Ph.D. in 2017. From 2004 to 2016, Dr. Reddy worked at GVK BIO as an Associate Scientist, contributing to contract research projects associated with DuPont. He subsequently joined Coromandel International Limited in 2016, where he worked in Process R&D to the position of Manager. 

Since 2025, Dr. Reddy has been associated with Daisa Biopharma as a Scientist in Process R&D. His current research focuses on the development and optimization of processes for APIs and advanced pharmaceutical intermediates. 

dr-kobirul-islam-daisa-biopharma

Dr. Kobirul Islam

Principal Scientist - 2

Dr. Kobirul Islam earned his Ph.D. in 2017 from the Indian Institute of Technology Guwahati, where he developed novel synthetic methodologies and multicomponent reactions under the supervision of Abu T. Khan.

Discover Our Vision

Take a closer look at how our teams collaborate to transform breakthrough ideas into impactful research outcomes.